Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells 1,498 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 1,498 shares of the business’s stock in a transaction on Friday, April 26th. The shares were sold at an average price of $369.92, for a total transaction of $554,140.16. Following the completion of the sale, the executive vice president now directly owns 5,507 shares in the company, valued at $2,037,149.44. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Robert Desantis also recently made the following trade(s):

• On Monday, April 29th, Robert Desantis sold 376 shares of Intuitive Surgical stock. The shares were sold at an average price of $375.39, for a total transaction of $141,146.64.
• On Monday, March 11th, Robert Desantis sold 329 shares of Intuitive Surgical stock. The shares were sold at an average price of $390.16, for a total transaction of $128,362.64.
• On Friday, March 8th, Robert Desantis sold 20,296 shares of Intuitive Surgical stock. The shares were sold at an average price of $393.80, for a total transaction of $7,992,564.80.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $371.70 on Thursday. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $403.76. The firm has a market cap of $131.84 billion, a P/E ratio of 67.09, a price-to-earnings-growth ratio of 4.83 and a beta of 1.36. The firm’s 50-day simple moving average is $385.79 and its 200 day simple moving average is $348.35.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. The business had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. Intuitive Surgical’s quarterly revenue was up 11.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.00 EPS. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on ISRG shares. Piper Sandler lifted their price target on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research note on Friday, April 19th. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, April 8th. Citigroup boosted their price objective on shares of Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Raymond James boosted their price objective on shares of Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a research note on Thursday, January 25th. Finally, Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a research note on Friday, January 19th. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $396.17.

Institutional Trading of Intuitive Surgical

Institutional investors have recently bought and sold shares of the business. Baystate Wealth Management LLC boosted its holdings in Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 45 shares during the period. MCF Advisors LLC boosted its holdings in Intuitive Surgical by 108.1% in the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 40 shares during the period. Able Wealth Management LLC bought a new stake in Intuitive Surgical in the 4th quarter valued at about $28,000. Atticus Wealth Management LLC boosted its holdings in Intuitive Surgical by 85.4% in the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 41 shares during the period. Finally, MeadowBrook Investment Advisors LLC bought a new stake in Intuitive Surgical in the 4th quarter valued at about $30,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.